MENU
+Compare
IMNN
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$5.75
Change
+$0.04 (+0.70%)
Capitalization
14.51M

IMNN Imunon Inc Forecast, Technical & Fundamental Analysis

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies... Show more

IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IMNN with price predictions
Sep 05, 2025

IMNN's RSI Indicator sits in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMNN advanced for three days, in of 185 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IMNN as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for IMNN moved below the 200-day moving average on August 12, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMNN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IMNN entered a downward trend on September 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.423) is normal, around the industry mean (20.107). P/E Ratio (0.000) is within average values for comparable stocks, (52.767). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.138). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (327.388).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IMNN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMNN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IMNN is expected to report earnings to fall 90.23% to -20 cents per share on November 17

Imunon Inc IMNN Stock Earnings Reports
Q3'25
Est.
$-0.21
Q2'25
Missed
by $1.83
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.11
Q3'24
Beat
by $0.05
The last earnings report on August 05 showed earnings per share of -215 cents, missing the estimate of -31 cents. With 34.99K shares outstanding, the current market capitalization sits at 14.51M.
A.I. Advisor
published General Information

General Information

a company which engages in the provision of oncology drug development services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
997 Lenox Drive
Phone
+1 609 896-9100
Employees
33
Web
https://www.imunon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCTX7.870.15
+2.01%
Briacell Therapeutics Corp NEW
TMDX104.01-0.04
-0.04%
TransMedics Group
KB78.13-0.09
-0.12%
KB Financial Group
BJRI33.56-0.34
-1.00%
BJ's Restaurants
TEAD1.63-0.04
-2.40%
Teads Holding Co

IMNN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNN has been loosely correlated with ABVX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNN jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
+0.61%
ABVX - IMNN
58%
Loosely correlated
+2.90%
REPL - IMNN
57%
Loosely correlated
+8.95%
MRUS - IMNN
32%
Poorly correlated
+1.87%
CLSD - IMNN
30%
Poorly correlated
-1.23%
STOK - IMNN
30%
Poorly correlated
+5.35%
More